Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18240005 | 1.00 | DNM1 (0.56) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL7778179 | 1.00 | DNM1 (0.56) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL11101061 | 1.00 | DNM1 (0.56) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL6180238 | 1.00 | DNM1 (0.56) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL3260445 | 0.97 | DNM1 (0.52) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL21540429 | 0.88 | DNM1 (0.47) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL338812 | 0.88 | ADRB2 (0.45) | DNM1THRBTSHRCA1CA2 | |
| SCHEMBL28722243 | 0.81 | DNM1 (0.45) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL11259010 | 0.81 | DNM1 (0.45) | DNM1THRBTSHRMEN1HTT | |
| SCHEMBL23561835 | 0.80 | DNM1 (0.54) | DNM1THRBTSHRMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113710723-B | Use of functionalized alpha-angelicalactone | 汉高股份有限及两合公司 | 2024-06-18 | — | — | CN | disclosed |
| US-11697643-B2 | Use of functionalized alpha-angelica lactones | HENKEL AG & CO. KGAA (DE) | 2023-07-11 | — | — | US | disclosed |
| EP-3725784-B1 | A PROCESS FOR THE CHAIN GROWTH POLYMERIZATION OF FUNCTIONALIZED ALPHA-ANGELICA LACTONE MONOMERS | HENKEL AG & CO KGAA (DE) | 2022-06-29 | — | — | EP | disclosed |
| EP-3725820-B1 | USE OF FUNCTIONALIZED ALPHA-ANGELICA LACTONES | HENKEL AG & CO KGAA (DE) | 2022-04-06 | — | — | EP | disclosed |
| US-20220033370-A1 | FUNCTIONALIZED A- ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM | HENKEL AG & CO. KGAA (DE) | 2022-02-03 | — | — | US | disclosed |
| CN-113710723-A | Use of functionalized alpha-angelicin | 汉高股份有限及两合公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-113692404-A | Functionalized alpha-angelicalactone monomers and polymers obtained therefrom | 汉高股份有限及两合公司 | 2021-11-23 | — | — | CN | disclosed |
| WO-2020212149-A1 | USE OF FUNCTIONALIZED ALPHA-ANGELICA LACTONES | HENKEL AG & CO. KGAA (DE) | 2020-10-22 | — | — | WO | disclosed |
| WO-2020212041-A1 | FUNCTIONALIZED α-ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM | HENKEL AG & CO. KGAA (DE) | 2020-10-22 | — | — | WO | disclosed |
| EP-3725784-A1 | FUNCTIONALIZED ALPHA-ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM | Henkel AG & Co. KGaA (DE) | 2020-10-21 | — | — | EP | disclosed |
| EP-3725820-A1 | USE OF FUNCTIONALIZED ALPHA-ANGELICA LACTONES | Henkel AG & Co. KGaA (DE) | 2020-10-21 | — | — | EP | disclosed |
| US-20080220288-A1 | Light-Emitting Device, And Method For The Manufacture Thereof | KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) | 2008-09-11 | — | — | US | disclosed |
| CN-101263617-A | Light-emitting device, and method for the manufacture thereof | KONINKL PHILIPS ELECTRONICS NV (NL) | 2008-09-10 | — | — | CN | disclosed |
| EP-1927145-A2 | LIGHT-EMITTING DEVICE, AND METHOD FOR THE MANUFACTURE THEREOF | Koninklijke Philips Electronics N.V. (NL) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007031923-A2 | LIGHT-EMITTING DEVICE, AND METHOD FOR THE MANUFACTURE THEREOF | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2007-03-22 | — | — | WO | disclosed |
| US-20040082549-A1 | Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections | JOMAA HASSAN (DE) | 2004-04-29 | — | — | US | disclosed |
| US-6680308-B1 | ADMINISTERING N-(FORMYL OR ACETYL)-N-HYDROXYLAMINO)-ALKYLPHOSPHONIC ACID DERIVATIVE AS VIRICIDE, PARASITICIDE OR FUNGICIDE | BIOAGENCY AG (DE) | 2004-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033370-A1 | FUNCTIONALIZED A- ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM | AS3MT, EBPL, ACSL6 | DNM1 4157/4885THRB 4209/4885TSHR 3080/4885 |
| US-20040082549-A1 | Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections | PON1, DDT, GPX1 | DNM1 819/4885THRB 1366/4885TSHR 1150/4885 |
| US-11697643-B2 | Use of functionalized alpha-angelica lactones | RXRA, ERGIC1, RXRB | DNM1 3908/4885THRB 3436/4885TSHR 3190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.